AstraZeneca's Covid-19 antibody combination receives EU approval
20 Sep 2022
ShareCast

Drugmaker AstraZeneca said on Tuesday that Evusheld, its long-acting antibody combination, had been granted approval for the treatment of adults and adolescents with Covid-19 in the European Union.
ATTENTION
From now on, your password will need to comply with the following rules:
- Minimum length of 6 characters
- At least one lower case letter
- At least one capital letter
- At least one number
- At least one of the following characters: ! , ; . : - _
Click below on "Forgot password?" to change it if it does not comply with the above rules